Viral warts
Conditions
Interventions
Experimental group:Treated by intratumoral injection of podofilox
Control group:Treated by electrocautery
Sponsors
Chinese People's Liberation Army Navy Characteristic Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.The clinical symptoms and signs of the patients are in line with the diagnostic criteria for viral warts in "Clinical Dermatology"; 2.The patients are aged over 14 years and under 60 years; 3.The patients have not received any pesticide treatment for viral warts before the trial; they have no severe allergy to the drugs used and are willing to adhere to the medication as prescribed by the doctor; 4.The patients have given informed consent and voluntarily participate in this clinical study.
Exclusion criteria
Exclusion criteria: 1.Patients who have been treated for viral warts; 2.Patients with any other coexisting skin diseases that may interfere with the treatment effect; 3.Patients with any history of allergy to the study drug, pregnant or lactating women, or women planning to conceive in the near future; 4.Patients with a history of systemic lupus erythematosus, rheumatoid arthritis or other immune diseases or serious systemic diseases (clear history of central nervous system, cardiovascular system, renal system, liver system, respiratory system, metabolic and musculoskeletal system), or patients currently undergoing tumor treatment; 5.Patients with abnormal renal and liver function or known chronic infectious diseases; 6.Patients with poor compliance, or those who are critically ill and unable to complete the treatment course, or those judged by the researcher to have other factors that make them unsuitable for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of skin lesions;Size of the lesion; | — |
Countries
China
Contacts
Public ContactWa Bo
Chinese People's Liberation Army Navy Characteristic Medical Center
Outcome results
None listed